Luteolin-7-glucoside inhibits IL-22/STAT3 pathway, reducing proliferation, acanthosis and inflammation in keratinocytes and in mouse psoriatic model

22 Again: IL-22 as a Risk Gene and Important Mediator in Psoriasis

(2014) Andrew Johnston et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Genetic Variants of the IL22 Promoter Associate to Onset of Psoriasis before Puberty and Increased IL-22 Production in T Cells

(2014) Pernilla Nikamo et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Oxidative stress and psoriasis: the effect of antitumour necrosis factor-α inhibitor treatment

(2013) T. Bacchetti et al.   BRITISH JOURNAL OF DERMATOLOGY

STAT3 Phosphorylation at Tyrosine 705 and Serine 727 Differentially Regulates Mouse ESC Fates

(2013) Guanyi Huang et al.   STEM CELLS

Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases

(2012) Daniele Del Rio et al.   ANTIOXIDANTS & REDOX SIGNALING

Efficacy of Daphne oleoides subsp. kurdica used for wound healing: Identification of active compounds through bioassay guided isolation technique

(2012) Ipek Süntar et al.   JOURNAL OF ETHNOPHARMACOLOGY

Novel transglutaminase 1 mutations in patients affected by lamellar ichthyosis

(2012) A Terrinoni et al.   Cell Death & Disease

Anti-apoptotic effects of suppressor of cytokine signaling 3 and 1 in psoriasis

(2012) S Madonna et al.   Cell Death & Disease

MicroRNA-203 contributes to skin re-epithelialization

(2012) G Viticchiè et al.   Cell Death & Disease

Keratin disorders: from gene to therapy

(2011) W. H. I. McLean et al.   HUMAN MOLECULAR GENETICS

IL-22 Is Required for Imiquimod-Induced Psoriasiform Skin Inflammation in Mice

(2011) A. B. Van Belle et al.   JOURNAL OF IMMUNOLOGY

Effects of Flavonoids on Prostaglandin E2Production and on COX-2 and mPGES-1 Expressions in Activated Macrophages

(2011) Mari Hämäläinen et al.   PLANTA MEDICA

Pathobiology of Chronic Inflammatory Skin Diseases: Interplay Between Keratinocytes and Immune Cells as a Target for Anti-Inflammatory Drugs

(2010) C. Albanesi et al.   CURRENT DRUG METABOLISM

STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation

(2010) Rosanna Sestito et al.   FASEB JOURNAL

Stat3 as a Therapeutic Target for the Treatment of Psoriasis: A Clinical Feasibility Study with STA-21, a Stat3 Inhibitor

(2010) Ken Miyoshi et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Antiasthmatic Activity of Luteolin-7-O-glucoside from Ailanthus altissima through the Downregulation of T Helper 2 Cytokine Expression and Inhibition of Prostaglandin E2 Production in an Ovalbumin-Induced Asthma Model

(2009) Meihua Jin et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis

(2009) L. van der Fits et al.   JOURNAL OF IMMUNOLOGY

Distribution and Biological Activities of the Flavonoid Luteolin

(2009) Miguel Lopez-Lazaro   MINI-REVIEWS IN MEDICINAL CHEMISTRY

The Role of Redox Mechanisms in Cell Signalling

(2009) John T. Hancock   MOLECULAR BIOTECHNOLOGY

STAT3 inhibition of gluconeogenesis is downregulated by SirT1

(2009) Yongzhan Nie et al.   NATURE CELL BIOLOGY

p63 in epithelial development

(2008) E. Candi et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Skin stem cells: rising to the surface

(2008) Elaine Fuchs   JOURNAL OF CELL BIOLOGY

Lamellar Bodies of Human Epidermis

(2008) Anne-Aurélie Raymond et al.   MOLECULAR & CELLULAR PROTEOMICS

DGCR8-dependent microRNA biogenesis is essential for skin development

(2008) R. Yi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Molecular Mechanisms and Potential Clinical Significance of S-Glutathionylation

(2007) Isabella Dalle–Donne et al.   ANTIOXIDANTS & REDOX SIGNALING